E
Sutro Biopharma, Inc. STRO
$0.8578 $0.01021.20% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 76.05% -30.50% -333.20% 1.01% -24.64%
Total Depreciation and Amortization 6.15% 7.89% 7.91% 3.45% 3.41%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 111.38% 84.11% 410.05% -201.04% 421.12%
Change in Net Operating Assets -204.57% 44.96% 27.09% -290.27% 514.23%
Cash from Operations -573.02% -4.85% -609.79% -92.57% 130.31%
Capital Expenditure 88.62% -163.23% 25.88% -152.44% 52.87%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 103.35% -123.37% 501.21% 230.28% -217.50%
Cash from Investing 103.21% -125.36% 472.08% 229.18% -221.49%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 100.00% 100.00% 100.00%
Issuance of Common Stock -100.00% -76.07% -- 14.36% 9,110.59%
Repurchase of Common Stock -62.16% 51.87% -- -124.24% -516.67%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -100.06% 101.92% 99.23% 117.72% -29.91%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -265.05% -1,968.27% 225.15% 154.67% -85.19%